Loss of the Major GABAA Receptor Subtype in the Brain Is Not Lethal in Mice

Total Page:16

File Type:pdf, Size:1020Kb

Loss of the Major GABAA Receptor Subtype in the Brain Is Not Lethal in Mice The Journal of Neuroscience, May 15, 2001, 21(10):3409–3418 Loss of the Major GABAA Receptor Subtype in the Brain Is Not Lethal in Mice Cyrille Sur, Keith A. Wafford, David S. Reynolds, Karen L. Hadingham, Frances Bromidge, Alison Macaulay, Neil Collinson, Gillian O’Meara, Owain Howell, Richard Newman, Janice Myers, John R. Atack, Gerard R. Dawson, Ruth M. McKernan, Paul J. Whiting, and Thomas W. Rosahl Neuroscience Research Center, Merck Sharp and Dohme Research Laboratories, Harlow, Essex, CM20 2QR, United Kingdom ␣ ␤ ␥ ␣ Ϫ Ϫ The 1 2 2 is the most abundant subtype of the GABAA electrophysiological recordings from 1 / mice GABA cur- receptor and is localized in many regions of the brain. To gain rents in these neurons are dramatically reduced, and residual more insight into the role of this receptor subtype in the mod- currents have a benzodiazepine pharmacology characteristic of ulation of inhibitory neurotransmission, we generated mice ␣2- or ␣3-containing receptors. In contrast, the cerebellar Pur- lacking either the ␣1or␤2 subunit. In agreement with the kinje neurons from ␤2Ϫ/Ϫ mice have only a relatively small Ͼ ␤ Ϫ Ϫ reported abundance of this subtype, 50% of total GABAA reduction of GABA currents. In 2 / mice expression levels receptors are lost in both ␣1Ϫ/Ϫ and ␤2Ϫ/Ϫ mice. Surprisingly, of all six ␣ subunits are reduced by ϳ50%, suggesting that the homozygotes of both mouse lines are viable, fertile, and show ␤2 subunit can coassemble with ␣ subunits other than just ␣1. ␣ Ϫ Ϫ ␣ ␤ ␥ no spontaneous seizures. Initially half of the 1 / mice died Our data confirm that 1 2 2 is the major GABAA receptor prenatally or perinatally, but they exhibited a lower mortality subtype in the murine brain and demonstrate that, surprisingly, rate in subsequent generations, suggesting some phenotypic the loss of this receptor subtype is not lethal. drift and adaptive changes. Both adult ␣1Ϫ/Ϫ and ␤2Ϫ/Ϫ mice ␤ Ϫ Ϫ demonstrate normal performances on the rotarod, but 2 / Key words: GABAA receptor; mouse; cerebellum; radioli- mice displayed increased locomotor activity. Purkinje cells of gand; benzodiazepine; inhibitory current; locomotor activity; the cerebellum primarily express ␣1␤2␥2 receptors, and in rotarod The GABAergic system is the major contributor of the inhibitory heterozygotes have a normal life expectancy and demonstrate tone throughout the CNS. GABAA receptors are ligand-gated ion neophobia in a novel environment (Crestani et al., 1999). The channels that exist as a number of different subtypes. The lethality of the ␥2Ϫ/Ϫ mice can be rescued by transgenic overex- ␥ ␥ GABAA receptor is a pentameric structure, which is formed by pression of either the 2S or 2L subunit isoforms of the GABAA the coassembly of subunit polypeptides that exist in a large receptor indicating that both ␥2 subunit splice variants can sub- multigene family (McKernan and Whiting, 1996; Barnard et al., stitute for each other (Baer et al., 2000; Wick et al., 2000). Mice ␤ 1998). There are at least 16 different members of the GABAA lacking the 3 subunit of the GABAA receptor have cleft palate, receptor gene family, including 6␣,3␤,3␥, ␦, ⑀, ␪, and ␲ subunits epilepsy, and many behavioral characteristics of Angelman syn- (Whiting et al., 1999). The GABAA receptor genes are differen- drome (Culiat et al., 1995; Homanics et al., 1997; DeLorey et al., tially expressed both temporally and spatially throughout the 1998). Most of the ␤3Ϫ/Ϫ mice die as neonates, but the survivors, ␣ ␣ ␤ mammalian brain. For example the 2, 3, and 3 subunits are which are runted until weaning, can achieve normal body size by ␣ ␤ the major and subunits in the fetal brain, respectively, adulthood. In contrast, mice lacking the ␣6 subunit of the whereas the ␣1 and ␤2 subunits are mainly expressed after birth GABAA receptor, which is expressed exclusively in cerebellar (Zhang et al., 1991; Laurie et al., 1992b). Therefore, in the adult granule cells, have no major phenotypic abnormalities (Jones et ␣ ␤ ␥ brain the 1 2 2 subtype is the major subtype accounting for al., 1997). Expression of the ␦ subunit is inhibited in the ␣6Ϫ/Ϫ ϳ 43% of all GABAA receptors, whereas the remaining receptors mice, suggesting that both subunits form functional GABA ␣ ␣ A are made up mostly by 2- and 3-containing receptors together receptor subtypes in the cerebellar granule cells. Finally, mice with other combinations of quantitatively more minor GABAA deficient for the ␦ subunit are viable but show attenuated sensi- receptor subtypes (McKernan and Whiting, 1996). tivity to neuroactive steroids and epileptic seizures (Mihalek et Several mouse strains lacking individual GABAA receptor sub- al., 1999). units have been generated to study the physiological role of GABA receptors are the site of action of a number of clini- ␥ A GABAergic system in the living organism. Mice lacking the 2 cally important drugs, including benzodiazepines, barbiturates, subunit die shortly after birth (Gunther et al., 1995), whereas and anesthetics (Sieghart, 1995; Whiting et al., 1995). The ␣1␤2␥2 subtype is of particular interest in this context because it com- Received Dec. 19, 2000; revised Feb. 14, 2001; accepted Feb. 23, 2001. prises the major benzodiazepine binding site in the brain. We C.S., K.W., and D.R. contributed equally to different aspects of this work. addressed the question about the physiological role of this recep- Correspondence should be addressed to Dr. Thomas W. Rosahl, Merck Sharp and tor subtype by generating mice lacking either the ␣1or␤2 subunit Dohme Neuroscience Research Center, Terlings Park, Eastwick Road, Harlow, Essex, CM20 2QR, UK. E-mail: [email protected]. of the GABAA receptor which are thought to primarily coas- Copyright © 2001 Society for Neuroscience 0270-6474/01/213409-10$15.00/0 semble to form the ␣1␤2␥2 subtype. • 3410 J. Neurosci., May 15, 2001, 21(10):3409–3418 Sur et al. Mice Lacking the Major GABAA Receptor Subtype MATERIALS AND METHODS wild-type mice at postnatal days 11–17, and the vermal layer was isolated ␣ Ϫ Ϫ ␣ and placed into ice-cold oxygenated dissociation media containing (in Generation of 1 / mice. The GABAA receptor 1 gene-targeting mM): 82 Na SO ,30KSO , 5 MgCl , 10 HEPES buffer, and 10 glucose vector was constructed from the same genomic 129/SvEv ␭ fixII clone, 2 4 2 4 2 at pH 7.4. Tissue was then stirred for 7 min in 10 ml of dissociation media which has been used for the introduction of the ␣1H101R mutation containing 3 mg/ml of protease XXIII (Sigma) at 37°C. The tissue was (McKernan et al., 2000). However, for the complete gene knock-out, then washed in warmed oxygenated dissociation media containing 1 exon 4 was disrupted at the MscI restriction site by cloning the 1.2 kb mg/ml bovine serum albumin and 1 mg/ml trypsin inhibitor and main- BstBIϩMscI and the 7 kb EcoRVϩBamHI DNA fragment blunt-ended tained under oxygenating conditions at room temperature in Tyrode’s into the targeting vector. A phosphoglycerate kinase I (PGK) neo and a solution (in mM: 150 NaCl, 4 KCl, 2 CaCl , 2 MgCl , 10 HEPES, and 10 thymidine kinase (TK) cassette were also engineered blunt-ended into 2 2 glucose, pH 7.4). Tissue was withdrawn as needed and triturated with a the loxP site containing targeting vector. After linearization with NotI fire-polished Pasteur pipette to liberate individual cells. Cells were the targeting vector was introduced into AB2.2 embryonic stem (ES) plated onto a glass coverslip and left to settle for at least 30 min before cells (Lexicon Genetics) as described (Soriano et al., 1991; Rosahl et al., use. Purkinje cell bodies were identified by their characteristic size and 1993, 1995). Homologous recombinants were identified by PCR using the morphology. Cells could be used for up to 5 hr after preparation. primers 5Ј-ATTAATGGAGAGTGTGGTAATCTTT-3Ј and 5Ј-GGAT- Glass coverslips containing the dissociated cells were placed in a GCGGTGGGCTCTATGGCTTCTGA-3Ј and were further confirmed perspex recording chamber on the stage of a Nikon Diaphot inverted by genomic Southern blotting. Correctly targeted ES cell clones were microscope. Cells were perfused continuously with artificial CSF (aCSF) injected into C57BL6 blastocysts, and one of three clones gave rise to containing (in mM): 149 NaCl, 3.25 KCl, 2 CaCl , 2 MgCl , 10 HEPES, highly chimeric males, which transmitted the targeted allele into the germ 2 2 11 D-glucose, D(ϩ)-sucrose, pH 7.4, and observed with phase-contrast line. A colony of homozygous and wild-type control animals were estab- optics. Fire-polished patch pipettes were pulled on a WZ, DMZ- lished and used for the present study. Some ␣1Ϫ/Ϫ mice were crossed Universal puller (Zeitz-Instruments, Munich, Germany) using conven- with a cre-transgenic mouse (Schwenk et al., 1995) and further interbred tional 120TF-10 electrode glass. Pipette tip diameter was ϳ1.5–2.5 ␮M, to establish ␣1 homozygotes, which no longer contained the neomycin with resistances ϳ4M⍀. The intracellular solution contained (in mM): resistance gene marker. 130 CsCl, 10 HEPES, 10 BAPTA-Cs, 5 ATP-Mg, 0.1 leupeptin, and 1 Mice lacking the ␤2 subunit were generated in a similar way. A 17.5 kb MgCl , with 100 ␮M NaCO , pH-adjusted to 7.3 with CsOH and 320–340 genomic ␭/FixII clone containing exons 6, 7, and 8 of the ␤2 subunit was 2 3 mOsm. Cells were voltage-clamped at Ϫ60 mV using an Axopatch 200B subcloned into pBluescript via the NotI sites. An 8.5 kb SalI DNA amplifier (Axon Instruments, Foster City, CA). Drug solutions were fragment as a long arm and a 1.25 kb HpaI ϩ FspI DNA fragment as a applied to the cells via a multibarrel drug delivery system, which could short arm were cloned into the PGK neo and TK containing modified pivot the barrels into place using a stepping motor.
Recommended publications
  • Valerenic Acid Potentiates and Inhibits GABAA Receptors: Molecular Mechanism and Subunit Specificity
    ARTICLE IN PRESS + MODEL Neuropharmacology xx (2007) 1e10 www.elsevier.com/locate/neuropharm Valerenic acid potentiates and inhibits GABAA receptors: Molecular mechanism and subunit specificity S. Khom a, I. Baburin a, E. Timin a, A. Hohaus a, G. Trauner b, B. Kopp b, S. Hering a,* a Department of Pharmacology and Toxicology, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria b Department of Pharmacognosy, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria Received 8 December 2006; received in revised form 11 April 2007; accepted 30 April 2007 Abstract Valerian is a commonly used herbal medicinal product for the treatment of anxiety and insomnia. Here we report the stimulation of chloride currents through GABAA receptors (IGABA) by valerenic acid (VA), a constituent of Valerian. To analyse the molecular basis of VA action, we expressed GABAA receptors with 13 different subunit compositions in Xenopus oocytes and measured IGABA using the two-microelectrode voltage-clamp technique. We report a subtype-dependent stimulation of IGABA by VA. Only channels incorporating b2 or b3 subunits were stimulated by VA. Replacing b2/3 by b1 drastically reduced the sensitivity of the resulting GABAA channels. The stimulatory effect of VA on a1b2 receptors was substantially reduced by the point mutation b2N265S (known to inhibit loreclezole action). Mutating the corresponding residue of b1 (b1S290N) induced VA sensitivity in a1b1S290N comparable to a1b2 receptors. Modulation of IGABA was not significantly dependent on incorporation of a1, a2, a3 or a5 subunits. VA displayed a significantly lower efficiency on channels incorporating a4 subunits. IGABA modulation by VA was not g subunit dependent and not inhibited by flumazenil (1 mM).
    [Show full text]
  • GABA Receptors
    D Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews Review No.7 / 1-2011 GABA receptors Wolfgang Froestl , CNS & Chemistry Expert, AC Immune SA, PSE Building B - EPFL, CH-1015 Lausanne, Phone: +41 21 693 91 43, FAX: +41 21 693 91 20, E-mail: [email protected] GABA Activation of the GABA A receptor leads to an influx of chloride GABA ( -aminobutyric acid; Figure 1) is the most important and ions and to a hyperpolarization of the membrane. 16 subunits with γ most abundant inhibitory neurotransmitter in the mammalian molecular weights between 50 and 65 kD have been identified brain 1,2 , where it was first discovered in 1950 3-5 . It is a small achiral so far, 6 subunits, 3 subunits, 3 subunits, and the , , α β γ δ ε θ molecule with molecular weight of 103 g/mol and high water solu - and subunits 8,9 . π bility. At 25°C one gram of water can dissolve 1.3 grams of GABA. 2 Such a hydrophilic molecule (log P = -2.13, PSA = 63.3 Å ) cannot In the meantime all GABA A receptor binding sites have been eluci - cross the blood brain barrier. It is produced in the brain by decarb- dated in great detail. The GABA site is located at the interface oxylation of L-glutamic acid by the enzyme glutamic acid decarb- between and subunits. Benzodiazepines interact with subunit α β oxylase (GAD, EC 4.1.1.15). It is a neutral amino acid with pK = combinations ( ) ( ) , which is the most abundant combi - 1 α1 2 β2 2 γ2 4.23 and pK = 10.43.
    [Show full text]
  • Anxiety Disorders and GABA Neurotransmission: a Disturbance of Modulation
    Journal name: Neuropsychiatric Disease and Treatment Article Designation: REVIEW Year: 2015 Volume: 11 Neuropsychiatric Disease and Treatment Dovepress Running head verso: Nuss Running head recto: Anxiety and modulation open access to scientific and medical research DOI: http://dx.doi.org/10.2147/NDT.S58841 Open Access Full Text Article REVIEW Anxiety disorders and GABA neurotransmission: a disturbance of modulation Philippe Nuss1,2 Abstract: Lines of evidence coming from many branches of neuroscience indicate that anxiety 1Department of Psychiatry, Hôpital St disorders arise from a dysfunction in the modulation of brain circuits which regulate emotional Antoine, AP-HP, 2UMR 7203, INSERM responses to potentially threatening stimuli. The concept of anxiety disorders as a disturbance ERL 1057 – Bioactive Molecules of emotional response regulation is a useful one as it allows anxiety to be explained in terms Laboratory, Pierre and Marie Curie University, Paris, France of a more general model of aberrant salience and also because it identifies avenues for devel- oping psychological, behavioral, and pharmacological strategies for the treatment of anxiety disorder. These circuits involve bottom-up activity from the amygdala, indicating the presence of potentially threatening stimuli, and top-down control mechanisms originating in the prefron- tal cortex, signaling the emotional salience of stimuli. Understanding the factors that control cortical mechanisms may open the way to identification of more effective cognitive behavioral strategies for managing anxiety disorders. The brain circuits in the amygdala are thought to For personal use only. comprise inhibitory networks of γ-aminobutyric acid-ergic (GABAergic) interneurons and this neurotransmitter thus plays a key role in the modulation of anxiety responses both in the normal and pathological state.
    [Show full text]
  • Molecular Mechanisms of Antiseizure Drug Activity at GABAA Receptors
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Seizure 22 (2013) 589–600 Contents lists available at SciVerse ScienceDirect Seizure jou rnal homepage: www.elsevier.com/locate/yseiz Review Molecular mechanisms of antiseizure drug activity at GABAA receptors L. John Greenfield Jr.* Dept. of Neurology, University of Arkansas for Medical Sciences, 4301W. Markham St., Slot 500, Little Rock, AR 72205, United States A R T I C L E I N F O A B S T R A C T Article history: The GABAA receptor (GABAAR) is a major target of antiseizure drugs (ASDs). A variety of agents that act at Received 6 February 2013 GABAARs s are used to terminate or prevent seizures. Many act at distinct receptor sites determined by Received in revised form 16 April 2013 the subunit composition of the holoreceptor. For the benzodiazepines, barbiturates, and loreclezole, Accepted 17 April 2013 actions at the GABAAR are the primary or only known mechanism of antiseizure action. For topiramate, felbamate, retigabine, losigamone and stiripentol, GABAAR modulation is one of several possible Keywords: antiseizure mechanisms. Allopregnanolone, a progesterone metabolite that enhances GABAAR function, Inhibition led to the development of ganaxolone. Other agents modulate GABAergic ‘‘tone’’ by regulating the Epilepsy synthesis, transport or breakdown of GABA. GABAAR efficacy is also affected by the transmembrane Antiepileptic drugs chloride gradient, which changes during development and in chronic epilepsy. This may provide an GABA receptor Seizures additional target for ‘‘GABAergic’’ ASDs. GABAAR subunit changes occur both acutely during status Chloride channel epilepticus and in chronic epilepsy, which alter both intrinsic GABAAR function and the response to GABAAR-acting ASDs.
    [Show full text]
  • Characterisation of GABAA Receptors and Cation-Chloride Cotransporters in the Uterus and Their Role in Pre-Term Labour
    Characterisation of GABAA receptors and cation-chloride cotransporters in the uterus and their role in pre-term labour Melissa Linda Sutherland December 2017 Supervisors: Dr. Amy V. Poole, Dr. Jennifer A. Fraser, Dr. Claire Garden. A thesis submitted in partial fulfilment of the requirements of Edinburgh Napier University, for the award of Master by Research Declaration It is hereby declared that this thesis is the result of the author’s original research. It has been composed by the author and has not been previously submitted for examination, which has led to the award of a degree or professional qualification. Signed: Date: Contents page Abbreviations .............................................................................................. 1 Acknowledgements ................................................................................... 3 Abstract ......................................................................................................... 4 CHAPTER 1. Introduction ......................................................................... 5 1.1-aminobutyric acid (GABA) .............................................................. 5 1.2 GABA receptor structure and function .......................................... 5 Figure 1.1 Schematic diagram of the GABAA subunit and receptor ......................................................................................................... 6 1.3 GABAARs role in development central nervous system ..........................................................................................................
    [Show full text]
  • Ion Channels
    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
    [Show full text]
  • Analysis of B-Subunit-Dependent GABA a Receptor Modulation And
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2016/04/18/jpet.116.232983.DC1 1521-0103/357/3/580–590$25.00 http://dx.doi.org/10.1124/jpet.116.232983 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 357:580–590, June 2016 Copyright ª 2016 The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. Analysis of b-Subunit-dependent GABAA Receptor Modulation and Behavioral Effects of Valerenic Acid Derivatives s S. Khom,1 J. Hintersteiner,2 D. Luger,2 M. Haider, G. Pototschnig, M. D. Mihovilovic, C. Schwarzer,1 and S. Hering Department of Pharmacology and Toxicology, University of Vienna, Vienna, Austria (S.K., J.H., D.L., S.H.); Institute of Applied Synthetic Chemistry, TU Wien, Vienna, Austria (M.H., G.P., M.D.M.); and Department of Pharmacology, Medical University of Innsbruck, Innsbruck, Austria (C.S.) Received February 20, 2016; accepted April 6, 2016 Downloaded from ABSTRACT Valerenic acid (VA)—a b2/3-selective GABA type A (GABAA) 40.4 6 1.4 mg/kg PTZ versus VA 10 mg/kg: 49.0 6 1.8 mg/kg receptor modulator—displays anxiolytic and anticonvulsive ef- PTZ versus VA-A 3 mg/kg: 57.9 6 1.9 mg/kg PTZ, P , 0.05). fects in mice devoid of sedation, making VA an interesting drug Similarly, VA’s methylamide (VA-MA) enhancing IGABA through candidate. Here we analyzed b-subunit-dependent enhance- b3-containing receptors more efficaciously than VA (Emax 5 jpet.aspetjournals.org ment of GABA-induced chloride currents (IGABA) by a library of VA 1043 6 57%, P , 0.01, n 5 6) displayed stronger anticonvulsive derivatives and studied their effects on pentylenetetrazole (PTZ)- effects.
    [Show full text]
  • The GABAA Receptor Interface: a Novel Target for Subtype Selective Drugs
    870 • The Journal of Neuroscience, January 19, 2011 • 31(3):870–877 Cellular/Molecular ␣ϩ␤Ϫ The GABAA Receptor Interface: A Novel Target for Subtype Selective Drugs Joachim Ramerstorfer, Roman Furtmu¨ller, Isabella Sarto-Jackson, Zdravko Varagic, Werner Sieghart, and Margot Ernst Department of Biochemistry and Molecular Biology, Center for Brain Research, Medical University Vienna, Austria GABAA receptorsmediatetheactionofmanyclinicallyimportantdrugsinteractingwithdifferentbindingsites.Forsomepotentialbindingsites, no interacting drugs have yet been identified. Here, we established a steric hindrance procedure for the identification of drugs acting at the extracellular ␣1ϩ␤3Ϫ interface, which is homologous to the benzodiazepine binding site at the ␣1ϩ␥2Ϫ interface. On screening of Ͼ100 benzodiazepine site ligands, the anxiolytic pyrazoloquinoline 2-p-methoxyphenylpyrazolo[4,3Ϫc]quinolin-3(5H)-one (CGS 9895) was able to enhance GABA-induced currents at ␣1␤3 receptors from rat. CGS 9895 acts as an antagonist at the benzodiazepine binding site at nanomolar concentrations, but enhances GABA-induced currents via a different site present at ␣1␤3␥2 and ␣1␤3 receptors. By mutating pocket-forming amino acid residues at the ␣1ϩ and the ␤3Ϫ side to cysteines, we demonstrated that covalent labeling of these cysteines by the methanethio- sulfonate ethylamine reagent MTSEA-biotin was able to inhibit the effect of CGS 9895. The inhibition was not caused by a general inactivation of ␣ GABAA receptors, because the GABA-enhancing effect of ROD 188 or the steroid -tetrahydrodeoxycorticosterone was not influenced by MTSEA-biotin. Other experiments indicated that the CGS 9895 effect was dependent on the ␣ and ␤ subunit types forming the interface. CGS ␣ϩ␤Ϫ 9895thusrepresentsthefirstprototypeofdrugsmediatingbenzodiazepine-likemodulatoryeffectsviathe interfaceofGABAAreceptors. Sincesuchbindingsitesarepresentat␣␤,␣␤␥,and␣␤␦receptors,suchdrugswillhaveamuchbroaderactionthanbenzodiazepinesandmight become clinical important for the treatment of epilepsy.
    [Show full text]
  • Major Differences in Inhibitory Synaptic Transmission Onto Two Neocortical Interneuron Subclasses
    9664 • The Journal of Neuroscience, October 22, 2003 • 23(29):9664–9674 Cellular/Molecular Major Differences in Inhibitory Synaptic Transmission onto Two Neocortical Interneuron Subclasses Alberto Bacci,1 Uwe Rudolph,2 John R. Huguenard,1 and David A. Prince1 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, and 2Institute of Pharmacology and Toxicology, University of Zu¨rich, CH-8057 Zu¨rich, Switzerland Locally projecting GABAergic interneurons are the major providers of inhibition in the neocortex and play a crucial role in several brain functions. Neocortical interneurons are connected via electrical and chemical synapses that may be crucial in modulating complex network oscillations. We investigated the properties of spontaneous and evoked IPSCs in two morphologically and physiologically identified interneuron subtypes, the fast-spiking (FS) and low threshold-spiking (LTS) cells in layer V of rodent sensorimotor cortex. We found that IPSCs recorded in FS cells were several orders of magnitude more frequent, larger in amplitude, and had faster kinetics than ␣ ␤ IPSCs recorded in LTS cells. GABAA receptor - and -subunit selective modulators, zolpidem and loreclezole, had different effects on IPSCs in FS and LTS interneurons, suggesting differential expression of GABAA receptor subunit subtypes. These pharmacological data ␣ indicated that the 1 subunit subtype is poorly expressed by LTS cells but makes a large contribution to GABAA receptors on FS cells. This was confirmed by experiments performed in genetically modified mice in which the ␣1 subunit had been made insensitive to benzodiazepine-like agonists. These results suggest that differences in IPSC waveform are likely attributable to distinctive expression of GABAA receptor subunits in FS and LTS cells.
    [Show full text]
  • GABA Receptors
    Tocris Scientific ReviewReview SeriesSeries Tocri-lu-2945 GABA Receptors Ian L. Martin, Norman G. Bowery Historical Perspective and Susan M.J. Dunn GABA is the major inhibitory amino acid transmitter of the Ian Martin is Professor of Pharmacology in the School of Life and mammalian central nervous system (CNS). Essentially all neurons Health Sciences, Aston University, Birmingham, UK. Norman in the brain respond to GABA and perhaps 20% use it as their 1 Bowery is Emeritus Professor of Pharmacology, University of primary transmitter. Early electrophysiological studies, carried Birmingham, UK. Susan Dunn is Professor and Chair at the out using iontophoretic application of GABA to CNS neuronal Department of Pharmacology, Faculty of Medicine and Dentistry, preparations, showed it to produce inhibitory hyperpolarizing 2 University of Alberta, Canada. All three authors share common responses that were blocked competitively by the alkaloid 3 interests in GABAergic transmission. E-mail: sdunn@pmcol. bicuculline. However, in the late 1970s, Bowery and his ualberta.ca colleagues, who were attempting to identify GABA receptors on peripheral nerve terminals, noted that GABA application reduced the evoked release of noradrenalin in the rat heart and that this Contents effect was not blocked by bicuculline. This action of GABA was Introduction ............................................................................................. 1 mimicked, however, by baclofen (Figure 1), a compound that was unable to produce rapid hyperpolarizing responses
    [Show full text]
  • Methoxy-6-Methylflavone and Kavain at Recombinant GABAA Receptors
    Pharmacology profile of 2′-methoxy-6-methylflavone and kavain at recombinant GABAA receptors Han Chow Chua BPharm (Hons) A thesis submitted in fulfilment of the requirements for the award of Doctor of Philosophy Faculty of Pharmacy The University of Sydney 2016 Acknowledgements Firstly, I would like to express my sincere gratitude to my supervisor Professor Mary Collins for her continuous support, guidance, patience and motivation throughout my PhD. Besides my supervisor, I would like to thank Professor Jane Hanrahan, Dr Nathan Absalom and Dr Petra van Nieuwenhuijzen for their insightful comments and encouragement, which were precious for the writing of this thesis. My sincere appreciation also goes to Associate Professor Philip Ahring for providing me with valuable guidance in molecular biology and electrophysiology; Associate Professor Thomas Balle for his immense knowledge in molecular modelling; Dr Raja Viswas for the synthesis of various chemicals used in this study. I would also like to thank my colleagues and lab buddies (in no particular order): Vivian, Irene, Radhika, Zirong, Taima, Leonny, Jia, Bryan, Ting, Steve, Terry, Tim, Izumi, Ida and Maja for their friendship, support, shared knowledge and experiences over the years, which helped me stay sane through those hair-pulling moments. Last but not least, my heartfelt gratitude goes to my family, as none of this would have been possible without their support. They have been a constant source of love, concern, support and strength throughout all these years and I deeply appreciate their faith in me. Abstract GABAA receptors (GABAARs) are a class of physiologically- and therapeutically- important ligand-gated ion channels.
    [Show full text]
  • GABAA Receptor Pharmacology and Subtype Mrna Expression in Human Neuronal NT2-N Cells
    The Journal of Neuroscience, July 1, 1998, 18(13):4993–5007 GABAA Receptor Pharmacology and Subtype mRNA Expression in Human Neuronal NT2-N Cells Torben R. Neelands,1 L. John Greenfield Jr,2 Jie Zhang,1,2 R. Scott Turner,1,2,4 and Robert L. Macdonald1,2,3 1Neuroscience Program and Departments of 2Neurology and 3Physiology, University of Michigan, and 4Veterans Affairs Medical Center Geriatric Research, Education, and Clinical Center, Ann Arbor, Michigan, 48104-1687 Human NT2 teratocarcinoma cells differentiate into neuron-like ately modulated GABAR currents. Zinc blocked GABAR cur- NT2-N cells when treated with retinoic acid. GABA evoked rents with low affinity, but lanthanum did not significantly alter concentration-dependent whole-cell currents in NT2-N cells NT2-N GABAR currents. Reverse transcription PCR (RT-PCR) m with an EC50 of 21.8 M and a Hill slope of 1.2. GABAA receptor performed on RNA from NT2-N cells clearly detected tran- a a a b g p (GABAR) currents reversed at ECl2 and did not display voltage- scripts encoding human 2, 3, 5, 3, 3, and subtypes. dependent rectification. GABAR single channels opened in The combined pharmacological and RT-PCR results are most bursts to a 23 pS main conductance level and a 19 pS sub- consistent with a single or predominant GABAR isoform com- conductance level, with infrequent openings to a 27 pS con- posed of an a2 and/or a3 subtype combined with the b3 and g3 ductance level. Kinetic properties of the main conductance subtypes. The data do not rule out receptors containing com- level were similar to other native and recombinant GABAR binations of a2 and/or a3 subtypes with the a5 subtype or channels.
    [Show full text]